Abstract: The subject invention provides pharmaceutical compositions Containing laquinimod or a pharmaceutically acceptable salt thereof an isolated compound of N ethyl 4 hydroxyl 1 methyl 5 (methyl (2 3 4 5 6 pentahydroxyhexyl) amino) 2 oxo N phenyl 1 2 dihydroquinoline 3 carboxamide or a salt thereof compositions containing N ethyl 4 hydroxyl 1 methyl 5 (methyl (2 3 4 5 6 pentahydroxyhexyl) amino) 2 oxo N phenyl 1 2 dihydroquinoline 3 carboxamide and methods of preparing the same.
| # | Name | Date |
|---|---|---|
| 1 | 2485-MUMNP-2014-AbandonedLetter.pdf | 2019-03-29 |
| 1 | Marked Copy [06-05-2016(online)].pdf | 2016-05-06 |
| 2 | Form 13 [06-05-2016(online)].pdf | 2016-05-06 |
| 2 | 2485-MUMNP-2014-FER.pdf | 2018-08-16 |
| 3 | Description(Complete) [06-05-2016(online)].pdf | 2016-05-06 |
| 3 | 2485-MUMNP-2014-Correspondence-210115.pdf | 2018-08-11 |
| 4 | spec.pdf | 2018-08-11 |
| 4 | 2485-MUMNP-2014-Form 3-210115.pdf | 2018-08-11 |
| 5 | Form 5.pdf | 2018-08-11 |
| 5 | 2485-MUMNP-2014-OTHERS-210115.pdf | 2018-08-11 |
| 6 | Form 3.pdf | 2018-08-11 |
| 6 | 2485-MUMNP-2014-Power of Attorney-210115.pdf | 2018-08-11 |
| 7 | Drawing.pdf | 2018-08-11 |
| 7 | 2485-MUMNP-2014.pdf | 2018-08-11 |
| 8 | ABSTRACT1.jpg | 2018-08-11 |
| 9 | Drawing.pdf | 2018-08-11 |
| 9 | 2485-MUMNP-2014.pdf | 2018-08-11 |
| 10 | 2485-MUMNP-2014-Power of Attorney-210115.pdf | 2018-08-11 |
| 10 | Form 3.pdf | 2018-08-11 |
| 11 | Form 5.pdf | 2018-08-11 |
| 11 | 2485-MUMNP-2014-OTHERS-210115.pdf | 2018-08-11 |
| 12 | spec.pdf | 2018-08-11 |
| 12 | 2485-MUMNP-2014-Form 3-210115.pdf | 2018-08-11 |
| 13 | Description(Complete) [06-05-2016(online)].pdf | 2016-05-06 |
| 13 | 2485-MUMNP-2014-Correspondence-210115.pdf | 2018-08-11 |
| 14 | Form 13 [06-05-2016(online)].pdf | 2016-05-06 |
| 14 | 2485-MUMNP-2014-FER.pdf | 2018-08-16 |
| 15 | Marked Copy [06-05-2016(online)].pdf | 2016-05-06 |
| 15 | 2485-MUMNP-2014-AbandonedLetter.pdf | 2019-03-29 |
| 1 | SearchStrategyof2485-MUMNP-2014_14-08-2018.pdf |